Sheng Ding

437 total citations
13 papers, 131 citations indexed

About

Sheng Ding is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Sheng Ding has authored 13 papers receiving a total of 131 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Sheng Ding's work include Pregnancy and preeclampsia studies (1 paper), Neurological Complications and Syndromes (1 paper) and Mesenchymal stem cell research (1 paper). Sheng Ding is often cited by papers focused on Pregnancy and preeclampsia studies (1 paper), Neurological Complications and Syndromes (1 paper) and Mesenchymal stem cell research (1 paper). Sheng Ding collaborates with scholars based in China and United States. Sheng Ding's co-authors include J B Zabriskie, Dharam V. Ablashi, Jacqueline Friedman, Robert D. Zimmerman, Otto Rapalino, Randall C. Edgell, Ting Yan, Jinling Xu, Yongqiang Zheng and Li Zou and has published in prestigious journals such as Immunity, Gastroenterology and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Sheng Ding

10 papers receiving 127 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng Ding China 7 30 29 28 27 23 13 131
Christoph Haudum Austria 8 18 0.6× 19 0.7× 11 0.4× 68 2.5× 15 0.7× 20 173
Shaofen Zhang China 9 20 0.7× 44 1.5× 8 0.3× 25 0.9× 10 0.4× 24 232
Han-Sang Baek South Korea 9 15 0.5× 44 1.5× 38 1.4× 48 1.8× 62 2.7× 31 259
Lorna Galleguillos Chile 8 105 3.5× 49 1.7× 22 0.8× 58 2.1× 19 0.8× 16 209
Yoshimitsu Kitajima Japan 11 4 0.1× 39 1.3× 23 0.8× 62 2.3× 29 1.3× 14 335
В. В. Тыренко Russia 5 23 0.8× 11 0.4× 5 0.2× 46 1.7× 14 0.6× 44 128
Jessica Camacho Spain 7 7 0.2× 21 0.7× 35 1.3× 55 2.0× 11 0.5× 14 156
James P. Cook United Kingdom 8 18 0.6× 17 0.6× 5 0.2× 52 1.9× 30 1.3× 12 202
Anita Neroni Italy 8 17 0.6× 68 2.3× 13 0.5× 59 2.2× 24 1.0× 14 198
S Macheiner Austria 4 8 0.3× 62 2.1× 45 1.6× 67 2.5× 53 2.3× 4 200

Countries citing papers authored by Sheng Ding

Since Specialization
Citations

This map shows the geographic impact of Sheng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Ding more than expected).

Fields of papers citing papers by Sheng Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Ding. The network helps show where Sheng Ding may publish in the future.

Co-authorship network of co-authors of Sheng Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Ding. A scholar is included among the top collaborators of Sheng Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Ding. Sheng Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Tan, Pengcheng, et al.. (2025). The transcription factor MEF2C restrains microglial overactivation by inhibiting kinase CDK2. Immunity. 58(4). 946–960.e10. 3 indexed citations
2.
Ding, Sheng, Jinling Xu, Jie Tong, et al.. (2025). Brown adipose tissue alleviates podocyte apoptosis through NRG4 in a male mouse model of diabetic kidney disease. Diabetologia. 68(5). 1057–1075. 3 indexed citations
4.
Ding, Sheng, Yi Yang, Jinling Xu, et al.. (2023). Diagnostic Value of the Combined Measurement of Serum HCY and NRG4 in Type 2 Diabetes Mellitus with Early Complicating Diabetic Nephropathy. Journal of Personalized Medicine. 13(3). 556–556. 6 indexed citations
5.
Xu, Jinling, et al.. (2023). Myeloid-derived growth factor and its effects on cardiovascular and metabolic diseases. Cytokine & Growth Factor Reviews. 76. 77–85. 6 indexed citations
6.
Xu, Jinling, Hui Zhou, Yangyang Cheng, et al.. (2023). Inflammatory Cell–Derived MYDGF Attenuates Endothelial LDL Transcytosis to Protect Against Atherogenesis. Arteriosclerosis Thrombosis and Vascular Biology. 43(11). e443–e467. 15 indexed citations
7.
Ding, Sheng, et al.. (2022). Emotional responses of piglets under long-term exposure to negative and positive auditory stimuli. Domestic Animal Endocrinology. 82. 106771–106771. 7 indexed citations
8.
Ding, Sheng, et al.. (2022). Effect of adipose derived stem cells on the survival rate of long random pattern skin flap in rats, and the underlying mechanism of action. Tropical Journal of Pharmaceutical Research. 22(2). 343–348.
10.
Yan, Ting, Kai Cui, Xiaowei Huang, et al.. (2013). Assessment of therapeutic efficacy of miR-126 with contrast-enhanced ultrasound in preeclampsia rats. Placenta. 35(1). 23–29. 27 indexed citations
11.
Wang, Fengchao, David Scoville, Xi He, et al.. (2013). 402 Isolation and Characterization of Intestinal Stem Cells Using Combinatorial Surface Markers and Robust Clonal Assay. Gastroenterology. 144(5). S–78. 1 indexed citations
12.
Wang, Zhongjing, Hong Mao, & Sheng Ding. (2008). Clinical observation on 36 patients with diabetic peripheral angiopathy after autologous hemopoietic stem cell transplantation. 31(19). 8–11.
13.
Friedman, Jacqueline, J B Zabriskie, Dharam V. Ablashi, et al.. (2005). A randomized clinical trial of valacyclovir in multiple sclerosis. Multiple Sclerosis Journal. 11(3). 286–295. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026